Procter & Gamble Pharmaceuticals Inc. has made a strategic decision to get out of early-stage pharmaceutical discovery research and instead acquire all of its new drugs from outside sources, the company said Friday.
Procter & Gamble Pharmaceuticals Inc. has made a strategic decision to get out of early-stage pharmaceutical discovery research and instead acquire all of its new drugs from outside sources, the company said Friday.
